Top news of the week: 01.12.2020.
#COVID19 #pharmaceuticals #treatment #thankful #coronavirus #biospace #lifesciences #biotechnology #pandemic #holiday
Companies And Industries
Thankful for Biopharma Breakthroughs
Despite the constant need for social distancing, mask-wearing, and the isolation and economic uncertainty that resulted from the outbreak, there is still much to be thankful for when ...
Biopharma nonprofit/grant deals triple that of 2019
The combined total of biopharma nonprofit collaborations and grants in 2020 has reached about $24 billion, more than three times the amount recorded for 2019.
As biopharma deals hit records in 2020, massive U.S. government funds flow into industry https://t.co/ja8K9uK3FQ
OpenAs biopharma deals hit records in 2020, massive U.S. government funds flow into industry
If there are three takeaways from this year’s dealmaking efforts, they appear to be record-setting partnerships, lackluster M&As, and massive amounts of research funding via the U.S. ...
The ‘halo effect’ of a pandemic: big money, strong market, but more drugs? https://t.co/6QPEYHP9DK
OpenThe ‘halo effect’ of a pandemic: big money, strong market, but more drugs?
More than a third of the money raised through biopharma financings in 2020 was raised by companies developing either a therapeutic or a vaccine for COVID-19, yet completely wiping away ...
The company starts out with $42 million from 5AM Ventures, Atlas Venture and Gimv that will push the program, KN-002, into the clinic next year https://t.co/gHj403i0gU
OpenKinaset Therapeutics debuts with $40M for pan-JAK asthma med
There is a host of treatments for people with asthma, from inhaled and oral corticosteroids to newer injected biologics. But these drugs don’t work for everyone, because different factors ...
Moderna sketches out 94.1% efficacy for COVID-19 vax based on more cases, with EUA plotted for today https://t.co/vRzK1lkHIR
OpenModerna sketches out 94.1% efficacy for COVID-19 vax based on more cases, with EUA plotted for today
As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure.
Cuba puts high hopes on second domestic vaccine against SARS-CoV-2
CAJICA, Colombia – Cuba’s Finlay Institute of Vaccines is moving forward with Soberana 2, a domestically developed conjugate vaccine against SARS-CoV-2. This is the second vaccine under ...
#GoodDayBIO: @DrMichelleBIO joined Fox News to discuss #COVID19 vaccine safety. Explaining how @Calyxt_Inc is developing breakthroughs that could help feed the world. Giving thanks for caregivers and the powerful role they play for patients. https://t.co/L5WzogA83j
OpenBut will they be safe?
Before we start cooking, we're getting Dr. Michelle’s perspective on whether COVID-19 vaccines will be safe, and giving thanks for CRISPR and caregivers. (737 words, 3 minutes, 40 seconds) ...